Efferon wants to eradicate the devastating toll of pediatric sepsis

Automated excerpt

Although Efferon makes absorbers for adults, Efferon NEO, its pediatric device developed specifically for young kids, is proving especially effective. Since children have a significantly lower circulating blood volume, they require medical devices engineered specifically for their physiology, according to Romashin. In April, Efferon NEO received a CE mark, Europe’s equivalent to FDA approval, making it the first multimodal blood purification device specifically engineered for pediatric sepsis.

Selected automatically from source text; not independently written or fact-checked. Read the original for full context.